ArticleAnnals of translational medicine2019

Effectiveness of hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat on renal anemia in non-dialysis-dependent chronic kidney disease: a systematic review and meta-analysis.

Linpei Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.